[DNA methylation and cancer]
- PMID: 17301518
[DNA methylation and cancer]
Abstract
Tumor suppressor genes can be silenced by DNA methylation during cancer development. Aberrant DNA methylation is closely associated with histone deacetylases and histone methyltransferases that can modify histone amino-terminal lysines and develop specific histone codes, resulting in inactive chromatin formation. These processes change epigenetic information that builds up abnormal chromatin structure, and creates the unique features of cancer cells. It is well known that thousands of genes are deregulated in cancer cells. Epigenetic alterations involving aberrant DNA methylation is a possible mechanism that can explain the genome-wide abnormality of gene expression. The mechanism responsible for the aberrant DNA methylation is unclear now, however it seems that de novo DNA methyltransferases (DNMTs) play an important role in the process. DNMT3 A and DNMT3B are thought to be de novo DNMTs in human. A nucleoside analogue of cytidine induces demethylation of DNA in cancer cells by inhibiting the function of DNMTs. It is significant to elucidate precise mechanisms of aberrant DNA methylation and develop small molecules that can inhibit methylation.
Similar articles
-
Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.FASEB J. 2008 Aug;22(8):3035-45. doi: 10.1096/fj.07-103390. Epub 2008 May 20. FASEB J. 2008. PMID: 18492726
-
Epigenetic mechanisms in glioblastoma multiforme.Semin Cancer Biol. 2009 Jun;19(3):188-97. doi: 10.1016/j.semcancer.2009.02.005. Epub 2009 Feb 20. Semin Cancer Biol. 2009. PMID: 19429483 Review.
-
Expression pattern of DNA-methyltransferases and its health implication (short review).Georgian Med News. 2014 Mar;(228):76-81. Georgian Med News. 2014. PMID: 24743128 Review.
-
Quercetin modifies 5'CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cells.J Cell Biochem. 2019 Oct;120(10):18357-18369. doi: 10.1002/jcb.29147. Epub 2019 Jun 6. J Cell Biochem. 2019. PMID: 31172592
-
(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.Oncol Rep. 2015 Apr;33(4):1976-84. doi: 10.3892/or.2015.3802. Epub 2015 Feb 13. Oncol Rep. 2015. PMID: 25682960
Cited by
-
DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study.World J Gastroenterol. 2007 Dec 7;13(45):6082-6. doi: 10.3748/wjg.v13.45.6082. World J Gastroenterol. 2007. PMID: 18023104 Free PMC article.
-
New insights into the diagnosis of nodular goiter.Thyroid Res. 2014 Jun 17;7:6. doi: 10.1186/1756-6614-7-6. eCollection 2014. Thyroid Res. 2014. PMID: 24987460 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
